You are Trying to View a Premium Article

Daily News You Can't Find Anywhere Else

Lupin Bets Big on Oncology in AbbVie-Partnership, Could Garner $1 Billion+, an Industrial Info Market Brief

pharmaceutical

Industry Segment: Pharmaceutical & Biotech | Word Count: 113 Words
Attachment: Lupin Pharma 0119

Indian pharmaceutical company Lupin Limited is eyeing major growth in its portfolio through a Novel Drug Discovery and Development (NDDD) program, focused on oncology, immunology and metabolic disorders

This Premium Article can be purchased individually or as part of a subscription

Subscribe Now! All Fields Required...

Subscription Type: Pricing Help?

  • Pay-Per-Article - $5.95
  • Annual Subscription - $235.00
  • Annual Subscription with Archive - $395.00